Patents by Inventor Ziao LIN

Ziao LIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240412814
    Abstract: The disclosure features compositions and methods that are useful for determining the fraction of tumor-derived DNA (tumor fraction; TF) in cell free DNA (cfDNA). The methods involve calculating the fraction of tumor-derived DNA in the cfDNA using a combination of copy number alteration data and fragment length distribution data.
    Type: Application
    Filed: August 23, 2024
    Publication date: December 12, 2024
    Applicants: The Broad Institute, Inc., President and Fellows of Harvard College, The General Hospital Corporation
    Inventors: Gad GETZ, Ziao LIN, Donald STEWART
  • Publication number: 20230287510
    Abstract: As described below, the present invention features compositions, panels of biomarkers, and methods for characterizing chronic lymphocytic leukemia (CLL) for prognosis and selection of a subject for a treatment and/or inclusion in a clinical trial.
    Type: Application
    Filed: August 9, 2021
    Publication date: September 14, 2023
    Applicants: The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc., The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Catherine J. WU, Gad GETZ, Binyamin A. KNISBACHER, Ziao LIN, Cynthia K. HAHN